May 18, 2020
Wize Pharma's Strategic Transaction Partner Bonus BioGroup Reports Successful Treatment of Acute Pneumonia in Preclinical COVID-19 Model
May 11, 2020
The Global Upper Respiratory Tract Infection Treatment Market is expected to grow by $ 1.79 billion during 2020-2024 progressing at a CAGR of 3% during the forecast period
Apr 21, 2020
Wize Pharma's Strategic Transaction Partner Bonus Biogroup Initiates Preclinical Study for Treatment of Respiratory Distress in COVID-19 Patients
Apr 01, 2020
VIDA Diagnostics Commended by Frost & Sullivan for Transforming Respiratory Disease Care Globally with its LungPrint Suite
Feb 24, 2020
Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance
Dec 02, 2019
CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis
Sep 26, 2019
New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
Sep 16, 2019
Gala Therapeutics Receives FDA Breakthrough Device Designation for the Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Sep 04, 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Mar 29, 2019
Peroxfarma to Bring 100 Percent Natural Epaplus Immuncare Cough Supplement to America
Jan 17, 2019
Gala Enrolls First Subject at Temple Lung Center as Part of the US Early Feasibility Trial of RheOx(TM) for Chronic Bronchitis in the United States
Nov 21, 2018
El Naturalista offers plant-based Muconatur that is traditionally used to soften the respiratory tract and mucus
Nov 05, 2018
Gala Enrolls First Subjects in an Early Feasibility Study of RheOx(TM) for Chronic Bronchitis in the United States
Sep 18, 2018
RejuvenAir® Metered Cryospray(TM) Shows Promise as Treatment for COPD Patients with Chronic Bronchitis
Sep 17, 2018
Gala Presents Positive Results from First-In-Human Clinical Trial of RheOx(TM) in Chronic Bronchitis at the European Respiratory Society
Aug 08, 2018
Data From First-In-Human RheOx(TM) Bronchial Rheoplasty Trial to be Presented at the European Respiratory Society
Jul 12, 2018
Gala Therapeutics Receives FDA IDE Approval for a US Early Feasibility Study of Its RheOx(TM) System to Treat Chronic Bronchitis
May 17, 2018
Pulmatrix selected to present company profile at the 2018 Respiratory Innovation Summit in San Diego
Apr 25, 2018
Respiratory Devices Market to Reach US$ 31.0 Bn by 2026, Says TMR
Mar 01, 2018
CSA Medical Announces the Completion of Treatments in the RejuvenAir Safety and Feasibility Study for patients with Chronic Bronchitis